292 related articles for article (PubMed ID: 15330324)
21. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of resistance tendency of bloodstream-infecting pathogens in China].
Lü Y; Li Y; Xue F; Zhang XZ; Hu YJ; Jin YF; Chu YZ; Hu ZD; Zhao JH; Pan SY; Zhao WS; Hu BJ; Yu YS; Deng QL; Yang J; Li Y; Liu WE; Lü XJ; Yang YJ; Zhou L; Dong F; Fu WL; Xu XL; Pei FY; Yang B; Meng L; Ji P; Wang S
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):411-9. PubMed ID: 24103203
[TBL] [Abstract][Full Text] [Related]
23. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
[TBL] [Abstract][Full Text] [Related]
24. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review.
Gentile RC; Shukla S; Shah M; Ritterband DC; Engelbert M; Davis A; Hu DN
Ophthalmology; 2014 Aug; 121(8):1634-42. PubMed ID: 24702755
[TBL] [Abstract][Full Text] [Related]
25. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.
Sader HS; Jones RN; Andrade-Baiocchi S; Biedenbach DJ;
Diagn Microbiol Infect Dis; 2002 Nov; 44(3):273-80. PubMed ID: 12493175
[TBL] [Abstract][Full Text] [Related]
26. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
Sader HS; Jones RN; Stilwell MG; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
Balode A; Punda-Polić V; Dowzicky MJ
Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections.
Yaman A; Tasova Y; Kibar F; Inal AS; Saltoglu N; Buyukcelik O; Kurtaran B; Dundar IH
Saudi Med J; 2004 Oct; 25(10):1403-9. PubMed ID: 15494811
[TBL] [Abstract][Full Text] [Related]
29. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
Bertrand X; Costa Y; Pina P
Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
[TBL] [Abstract][Full Text] [Related]
30. Frequency of Gram-negative bacterial pathogens in bloodstream infections and their resistance to antibiotics in the Czech Republic.
Cermák P; Kolár M; Látal T
Int J Antimicrob Agents; 2004 Apr; 23(4):401-4. PubMed ID: 15081092
[TBL] [Abstract][Full Text] [Related]
31. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe.
Obi CL; Mazarura E
Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012
[TBL] [Abstract][Full Text] [Related]
32. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
[TBL] [Abstract][Full Text] [Related]
34. [In vitro activity of trovafloxacin, of other fluoroquinolones and of related antimicrobials against clinical isolates. Grupo colaborativo WHONET-Argentina].
Rossi A; Galas M; Tokumoto M; Guelfand L; Lopardo H
Medicina (B Aires); 1999; 59 Suppl 1():8-16. PubMed ID: 10436549
[TBL] [Abstract][Full Text] [Related]
35. Ocular Pathogens and Antibiotic Sensitivity in Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, 2011 to 2014.
Al-Dhaheri HS; Al-Tamimi MD; Khandekar RB; Khan M; Stone DU
Cornea; 2016 Jun; 35(6):789-94. PubMed ID: 27078003
[TBL] [Abstract][Full Text] [Related]
36. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
38. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
[TBL] [Abstract][Full Text] [Related]
39. Patterns of isolation of common gram positive bacterial pathogens and their susceptibilities to antimicrobial agents in Jimma Hospital.
Gebreselassie S
Ethiop Med J; 2002 Apr; 40(2):115-27. PubMed ID: 12240573
[TBL] [Abstract][Full Text] [Related]
40. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Streit JM; Jones RN; Sader HS; Fritsche TR
Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]